• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.48% Nasdaq Up0.29%

    Cumberland Pharmaceuticals, Inc. (CPIX)

    -NasdaqGS
    4.55 Up 0.01(0.22%) 3:23PM EDT
    ProfileGet Profile for:
    Cumberland Pharmaceuticals, Inc.
    2525 West End Avenue
    Suite 950
    Nashville, TN 37203
    United States - Map
    Phone: 615-255-0068
    Fax: 615-255-0094
    Website: http://www.cumberlandpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:78

    Business Summary 

    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States and internationally. The company’s products portfolio comprise Acetadote injection for the treatment of acetaminophen poisoning; Caldolor injection for the treatment for pain and fever; Kristalose, a prescription laxative for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and related duodenal ulcer diseases; and Vaprisol injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia. Its products portfolio also include Hepatoren injection, which is in Phase II clinical trials for the treatment of critically ill hospitalized patients suffering from liver and kidney failure associated with hepatorenal syndrome; and Boxaban oral capsules that is in Phase II clinical trials for the treatment of patients with aspirin-exacerbated respiratory disease. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cumberland Pharmaceuticals, Inc.

    Corporate Governance 
    Cumberland Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 7. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 4; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. A. J. Kazimi MBA, 58
    Founder, Chairman, Chief Exec. Officer and Pres
    722.00K0.00
    Mr. Leo Pavliv R.Ph., 55
    Chief Devel. Officer and Sr. VP of Operations
    420.00K0.00
    Mr. James L. Herman , 61
    Chief Compliance Officer and VP of National Accounts
    253.00K0.00
    Mr. Martin E. Cearnal , 71
    Chief Commercial Officer, Sr. VP and Director
    339.00K0.00
    Dr. Gordon R. Bernard M.D., 64
    Sr. VP, Chairman of Medical Advisory Board, Director and Member of Governance & Nominating Committee
    85.00KN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders